Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
|---|---|---|---|---|---|
| 1 | Adherens junction 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 2 | Adherens junction 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 3 | Adherens junction 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 4 | Adherens junction 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 5 | AMPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 6 | AMPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 7 | AMPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 8 | AMPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 9 | Autophagy - animal 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 10 | Autophagy - animal 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 11 | Autophagy - animal 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 12 | Autophagy - animal 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 13 | Breast cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 14 | Breast cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 15 | Breast cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 16 | Breast cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 17 | Cadherin signaling 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 18 | Cadherin signaling 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 19 | Cadherin signaling 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 20 | Cadherin signaling 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 21 | Endocytosis 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 22 | Endocytosis 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 23 | Endocytosis 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 24 | Endocytosis 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 25 | Focal adhesion 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 26 | Focal adhesion 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 27 | Focal adhesion 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 28 | Focal adhesion 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 29 | FoxO signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 30 | FoxO signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 31 | FoxO signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 32 | FoxO signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 33 | Glioma 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 34 | Glioma 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 35 | Glioma 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 36 | Glioma 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 37 | Hepatocellular carcinoma 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 38 | Hepatocellular carcinoma 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 39 | Hepatocellular carcinoma 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 40 | Hepatocellular carcinoma 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 41 | HIF-1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 42 | HIF-1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 43 | HIF-1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 44 | HIF-1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 45 | Hormone signaling 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 46 | Hormone signaling 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 47 | Hormone signaling 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 48 | Hormone signaling 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 49 | Integrin signaling 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 50 | Integrin signaling 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 51 | Integrin signaling 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 52 | Integrin signaling 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 53 | Long-term depression 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 54 | Long-term depression 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 55 | Long-term depression 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 56 | Long-term depression 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 57 | Longevity regulating pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 58 | Longevity regulating pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 59 | Longevity regulating pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 60 | Longevity regulating pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 61 | Longevity regulating pathway - multiple species 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 62 | Longevity regulating pathway - multiple species 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 63 | Longevity regulating pathway - multiple species 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 64 | Longevity regulating pathway - multiple species 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 65 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 66 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 67 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 68 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 69 | Melanoma 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 70 | Melanoma 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 71 | Melanoma 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 72 | Melanoma 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 73 | mTOR signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 74 | mTOR signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 75 | mTOR signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 76 | mTOR signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 77 | Oocyte meiosis 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 78 | Oocyte meiosis 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 79 | Oocyte meiosis 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 80 | Oocyte meiosis 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 81 | Ovarian steroidogenesis 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 82 | Ovarian steroidogenesis 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 83 | Ovarian steroidogenesis 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 84 | Ovarian steroidogenesis 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 85 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 86 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 87 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 88 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 89 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 90 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 91 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 92 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 93 | Progesterone-mediated oocyte maturation 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 94 | Progesterone-mediated oocyte maturation 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 95 | Progesterone-mediated oocyte maturation 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 96 | Progesterone-mediated oocyte maturation 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 97 | Prostate cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 98 | Prostate cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 99 | Prostate cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 100 | Prostate cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 101 | Proteoglycans in cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 102 | Proteoglycans in cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 103 | Proteoglycans in cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 104 | Proteoglycans in cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 105 | Rap1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 106 | Rap1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 107 | Rap1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 108 | Rap1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 109 | Ras signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 110 | Ras signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 111 | Ras signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 112 | Ras signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 113 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 114 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 115 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 116 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
| 117 | Transcriptional misregulation in cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
| 118 | Transcriptional misregulation in cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 119 | Transcriptional misregulation in cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin rinfabate Mecasermin rinfabate 💬
| Mecasermin | 096 [4] 96, 168, 265, 299 💬
|
| 120 | Transcriptional misregulation in cancer 💬 1 gene, 3 drugs (DrugBank) and 6 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 049 [1] 49 💬
|
